Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 228

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Office-Based Opioid Treatment with Buprenorphine (OBOT-B): Statewide Implementation of the Massachusetts Collaborative Care Model in Community Health Centers

Open access
LaBelle, Colleen T., Han, Steve Choongheon, Bergeron, Alexis, Samet, Jeffrey H. · 2016 · Journal of Substance Abuse Treatment

Abstract

We describe a Massachusetts Bureau of Substance Abuse Services’ (BSAS) initiative to disseminate the office-based opioid treatment with buprenorphine (OBOT-B) Massachusetts Model from its development at Boston Medical Center (BMC) to its implementation at fourteen community health centers (CHCs) beginning in 2007. The Massachusetts Collaborative Care Model for the delivery of opioid agonist therapy with buprenorphine, in which nurses working with physicians play a central role in the evaluation and monitoring of patients, holds promise for the effective expansion of treatment for opioid use disorders. The training of and technical assistance for the OBOT nurses as well as a limited program assessment are described. Data spanning 6 years (2007 – 2013) reports patient demographics, prior treatment for opioid use disorders, history of overdose, housing, and employment. The expansion of OBOT to the fourteen CHCs increased the number of physicians who were “waivered” (i.e., enabling their prescribing of buprenorphine) by 375%, from 24 to 114, within 3 years. During this period the annual admissions of OBOT patients to CHCs markedly increased. Dissemination of the Massachusetts Model of the Office-Based Opioid Treatment with Buprenorphine employing a collaborative care model with a central role for nursing enabled implementation of effective treatment for patients with an opioid use disorder at community health centers throughout Massachusetts while effectively engaging primary care physicians in this endeavor.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jsat.2015.06.010

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 8

  1. Alford, 2007, Treating homeless opioid dependent patients with buprenorphine in an office-based setting, Journal of General Internal Medicine, 22, 171, 10.1007/s11606-006-0023-1 · DOI
  2. Barry, 2009, Integrating buprenorphine treatment into office-based practice: A qualitative study, Journal of General Internal Medicine, 24, 218, 10.1007/s11606-008-0881-9 · DOI
  3. Haddad, 2013, Integrating buprenorphine maintenance therapy into federally qualified health centers: Real-world substance abuse treatment outcomes, Drug and Alcohol Dependence, 131, 127, 10.1016/j.drugalcdep.2012.12.008 · DOI
  4. Kissin, 2006, Experiences of a national sample of qualified addiction specialists who have and have not prescribed buprenorphine for opioid dependence, Journal of Addictive Diseases, 25, 91, 10.1300/J069v25n04_09 · DOI
  5. Knapp, 2012, Implementation science in the real world: A streamlined model, Journal for Healthcare Quality, 34, 27, 10.1111/j.1945-1474.2012.00220.x · doi:10.1111/j.1945-1474.2012.00220.x
  6. Turner, 2005, Barriers and facilitators to primary care or human immunodeficiency virus clinics providing methadone or buprenorphine for the management of opioid dependence, Archives of Internal Medicine, 165, 1769, 10.1001/archinte.165.15.1769 · DOI
  7. Walley, 2008, Office-based management of opioid dependence with buprenorphine: Clinical practices and barriers, Journal of General Internal Medicine, 23, 1393, 10.1007/s11606-008-0686-x · DOI · Paper page
  8. Wesson, 2003, The clinical opiate withdrawal scale (COWS), Journal of Psychoactive Drugs, 35, 253, 10.1080/02791072.2003.10400007 · DOI · Paper page

Cited by

Metadata

Authors
LaBelle, C. T., Han, S. C., Bergeron, A., & Samet, J. H.
Venue
Journal of Substance Abuse Treatment
Publisher
Elsevier BV
Published
2016-01
Volume
60
Pages
6-13
ISSN
0740-5472 (ISSN-L)
OpenAlex
W789546000
Cited by
228
References
3
FWCI
12.94
Type
journal article
Language
en
Open access
green
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
  • Commonwealth of Massachusetts (0248908)
  • NIDA (R25DA013582)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.